TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+17.27%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$631M
AUM Growth
+$631M
(+93%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
36.03%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
2
Closed
2
Top Buys
| 1 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
$305M |
Top Sells
| 1 |
RXDX
Ignyta, Inc.
RXDX
|
$65M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$8.4M |
| 3 |
Heron Therapeutics
HRTX
|
$3.21M |
| 4 |
Cyclacel Pharmaceuticals
CYCC
|
$1.03M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $305M | 48.33% | +12,202,338 | New | +$305M |
|
|
2
Heron Therapeutics
HRTX
$207M
| $153M | 24.28% | 8,466,377 -177,362 | -2% | -$3.21M |
|
|
LJPC
3
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $111M | 17.54% | 3,440,419 | – | – |
|
|
RXDX
4
DELISTED
Ignyta, Inc.
RXDX
| $62.2M | 9.85% | 2,328,279 -2,435,323 | -51% | -$65M |
|
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – | -90,215 | Closed | -$8.4M |
|
|
6
Cyclacel Pharmaceuticals
CYCC
$18.4M
| – | – | -559,900 | Closed | -$1.03M |
|